Sarah Sammons, MD

Articles by Sarah Sammons, MD

Strategies to Identify and Delay Brain Metastases in HER2+ Breast Cancer

BySarah M. Tolaney, MD, MPH,Nancy U. Lin, MD,Sarah Sammons, MD,Adrienne Waks, MD,Ayal A. Aizer, MD, MHS

December 16th 2022

A brief review on how best to identify, delay, or avoid brain metastases in patients diagnosed with metastatic HER2+ breast cancer.

HER2+ Metastatic Breast Cancer: Factors in Selecting Optimal Therapy

BySarah M. Tolaney, MD, MPH,Nancy U. Lin, MD,Sarah Sammons, MD,Adrienne Waks, MD,Ayal A. Aizer, MD, MHS

December 16th 2022

Having outlined available treatment options for patients with HER2+ metastatic breast cancer, expert panelists share which factors help to select optimal therapy.

Treatment Armamentarium for HER2+ Metastatic Breast Cancer

BySarah M. Tolaney, MD, MPH,Nancy U. Lin, MD,Sarah Sammons, MD,Adrienne Waks, MD,Ayal A. Aizer, MD, MHS

December 9th 2022

Comprehensive insight to the treatment armamentarium for HER2+ metastatic breast cancer throughout several lines of therapy.

Patient Case 1: Patient With HER2+ Metastatic Breast Cancer and no CNS Disease

BySarah M. Tolaney, MD, MPH,Nancy U. Lin, MD,Ayal A. Aizer, MD, MHS,Sarah Sammons, MD,Adrienne Waks, MD

December 9th 2022

Expert panelists open their discussion on HER2+ breast cancer by reviewing a patient case of metastatic disease with no CNS involvement.

Sarah Sammons, MD

Articles by Sarah Sammons, MD

Strategies to Identify and Delay Brain Metastases in HER2+ Breast Cancer

HER2+ Metastatic Breast Cancer: Factors in Selecting Optimal Therapy

Treatment Armamentarium for HER2+ Metastatic Breast Cancer

Patient Case 1: Patient With HER2+ Metastatic Breast Cancer and no CNS Disease

Trending on CancerNetwork

Modifiable Risk Factors Suggest Potential for Improving Cancer Prevention

2026 Tandem Meetings: What’s the Latest Research in Multiple Myeloma?

Dato-DXd Receives Priority Review in Unresectable/Metastatic TNBC

Barriers to CAR T-Cell Referral and Center Access in Multiple Myeloma

Outlining Advances in AI For Breast Cancer Screening/Radiomics